Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
P. C. Iwen, S. H. Hinrichs & M. E. Rupp. (2002) Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Medical Mycology 40:1, pages 87-109.
Read now
Read now
Articles from other publishers (20)
Carmelo Massimo Maida, Maria Eleonora Milici, Laura Trovato, Salvatore Oliveri, Emanuele Amodio, Elisabetta Spreghini, Giorgio Scalise & Francesco Barchiesi. (2008) Evaluation of the Disk Diffusion Method Compared to the Microdilution Method in Susceptibility Testing of Anidulafungin against Filamentous Fungi. Journal of Clinical Microbiology 46:12, pages 4071-4074.
Crossref
Crossref
A.R. Khosravi, H. Shokri, P. Mansouri, F. Katiraee & T. Ziglari. (2008) Candida species isolated from nails and their in vitro susceptibility to antifungal drugs in the department of Dermatology (University of Tehran, Iran). Journal de Mycologie Médicale 18:4, pages 210-215.
Crossref
Crossref
V. V. Belakhov & Yu. D. Shenin. (2008) Synthesis and antifungal activity of N-trialkylsilyl derivatives of nystatin. Pharmaceutical Chemistry Journal 42:6, pages 322-325.
Crossref
Crossref
JACLYN H. CHU, CHARALAMPOS ANTACHOPOULOS & THOMAS J. WALSH. 2008. Pediatric Infectious Diseases. Pediatric Infectious Diseases
37
47
.
V. Blanc, O. Eloy, R. Sanchez & M. Mallié. (2005) Pratique de l'antifongigramme dans 62 hôpitaux français. Journal de Mycologie Médicale 15:4, pages 197-210.
Crossref
Crossref
H John SmithA Denver Russell & Claire Simons. 2005. Smith and Williams' Introduction to the Principles of Drug Design and Action, Fourth Edition. Smith and Williams' Introduction to the Principles of Drug Design and Action, Fourth Edition
557
615
.
Cornelius J. Clancy, Victor L. Yu, Arthur J. Morris, David R. Snydman & M. Hong Nguyen. (2005) Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia. Antimicrobial Agents and Chemotherapy 49:8, pages 3171-3177.
Crossref
Crossref
Farkad Ezzet, David Wexler, Rachel Courtney, Gopal Krishna, Josephine Lim & Mark Laughlin. (2005) Oral Bioavailability of Posaconazole in Fasted Healthy Subjects. Clinical Pharmacokinetics 44:2, pages 211-220.
Crossref
Crossref
D Wexler, R Courtney, W Richards, C Banfield, J Lim & M Laughlin. (2004) Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. European Journal of Pharmaceutical Sciences 21:5, pages 645-653.
Crossref
Crossref
L. D. Saravolatz, L. Ostrosky-Zeichner, K. A. Marr, J. H. Rex & S. H. Cohen. (2003) Amphotericin B: Time for a New "Gold Standard". Clinical Infectious Diseases 37:3, pages 415-425.
Crossref
Crossref
Nicholas A Kartsonis, Jennifer Nielsen & Cameron M Douglas. (2003) Caspofungin: the first in a new class of antifungal agents. Drug Resistance Updates 6:4, pages 197-218.
Crossref
Crossref
Todd DeZwaan, Keith Allen, Matthew Tanzer, Kiichi Adachi, Lakshman Ramamurthy, Sanjoy Mahanty & Lisbeth Hamer. 2003. Genomics of Plants and Fungi. Genomics of Plants and Fungi.
Johannes Müller, Annemarie Polak, Reinhard Kappe, Dagmar Rimek, Michael Seibold & Kathrin TintelnotAnnemarie Polak. 2003. Antifungal Agents. Antifungal Agents
59
190
.
Deanna A. Sutton. (2002) Laboratory evaluation of new antifungal agents against rare and refractory mycoses. Current Opinion in Infectious Diseases 15:6, pages 575-582.
Crossref
Crossref
Alicia Regueiro-Ren, Tina M. Carroll, Yijun Chen, James A. Matson, Stella Huang, Charles E. Mazzucco, Terry M. Stickle, Dolatrai M. Vyas & Balu N. Balasubramanian. (2002) Core-modified sordaricin derivatives: Synthesis and antifungal activity. Bioorganic & Medicinal Chemistry Letters 12:23, pages 3403-3405.
Crossref
Crossref
Sevtap Arikan, Victor Paetznick & John H. Rex. (2002)
Comparative Evaluation of Disk Diffusion with Microdilution Assay in Susceptibility Testing of Caspofungin against
Aspergillus
and
Fusarium
Isolates
. Antimicrobial Agents and Chemotherapy 46:9, pages 3084-3087.
Crossref
Crossref
Pamela A. Lipsett. (2002) Fungal Infections in Surgical Patients. Problems in General Surgery 19:1, pages 92-102.
Crossref
Crossref
John H. RexMichael A. PfallerThomas J. WalshVishnu ChaturvediAna Espinel-IngroffMahmoud A. GhannoumLinda L. GoseyFrank C. OddsMichael G. RinaldiDaniel J. Sheehan & David W. Warnock. (2001) Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clinical Microbiology Reviews 14:4, pages 643-658.
Crossref
Crossref
Jennifer M Fostel. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
R. A. Weinstein, J. H. Rex & J. D. Sobel. (2001) Prophylactic Antifungal Therapy in the Intensive Care Unit. Clinical Infectious Diseases 32:8, pages 1191-1200.
Crossref
Crossref